Lucintel’s latest market report analyzed that stem cell assay provides attractive opportunities in biopharmaceutical & biotechnology companies and academic & research institutes. The stem cell assay market is expected to reach $4.0 billion by 2028 with a CAGR of 19.1%. In this market, viability/cytotoxicity assay is the largest segment by type, whereas biopharmaceutical & biotechnology companies is largest by end use industry.
Download Brochure of this report by clicking on https://www.lucintel.com/stem-cell-assay-market.aspx
Based on type, the stem cell assay market is segmented into viability or cytotoxicity, isolation and purification, cell identification, and others. The viability/cytotoxicity assay segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
Browse in-depth TOC on “Stem Cell Assay Market”
100 – Figures/Tables
150 – Pages
The Stem cell assay Market is marked by the presence of several big and small players. Some of the prominent players offering stem cell assay include Thermo Fisher Scientific, Merck KGaA, Danaher, Becton, Dickinson and Company, Agilent Technologies, Bio-Techne Corporation, Lonza Group, PerkinElmer, Cell Biolabs, and Bio-Rad Laboratories.
Request Sample Report:
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected].
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Dallas, Texas, USA
Email: [email protected]
Roy Almaguer Lucintel Dallas, Texas, USA Email: [email protected] Tel. 972.636.5056
Reportedtimes, Extended Distribution, iCN Internal Distribution, Research Newswire, English